Avipep
Advertisement
Avipep Therapeutics, located in Parkville, Victoria, is dedicated to developing proprietary Avibody drug conjugates aimed at assisting patients battling relapsed and refractory cancer. Their innovative Avibody platform boasts superior biodistribution and tumor penetration compared to traditional antibodies, promising more effective treatment outcomes.
Clinical trials have demonstrated that Avibodies can efficiently penetrate tumors and maintain presence within them for several weeks while swiftly leaving the systemic circulation, which reduces toxicity. This technology allows for the delivery of potent therapeutic payloads using existing intact antibodies, marking a significant advancement in cancer treatment.
Generated from the website
You might also like
Advertisement